Clinical application and prospect of immune checkpoint inhibitors for CAR-NK cell in tumor immunotherapy

Chimeric antigen receptor (CAR) engineering of natural killer (NK) cells is an attractive research field in tumor immunotherapy. While CAR is genetically engineered to express certain molecules, it retains the intrinsic ability to recognize tumor cells through its own receptors. Additionally, NK cel...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kangdi Yang, Yuze Zhao, Guanqun Sun, Xu Zhang, Jinjin Cao, Mingcong Shao, Xijun Liang, Lina Wang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2023-01-01
coleção:	Frontiers in Immunology
Assuntos:	CAR-NK cell tumor immunotherapy immune checkpoint inhibitors clinical prospect
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1081546/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!